ISRG vs AMGN Stock Comparison

Intuitive Surgical and Amgen stock analysis with 20 years of historical data and interactive charts

Compare ISRG vs AMGN


ISRG

Stock Price (November 2005) $88.03
Stock Price (October 2025) $528.63
10-Year Growth 273.01%
20-Year Growth 645.92%
Market Cap (October 2025) $192.92 Billion

AMGN

Stock Price (November 2005) $75.25
Stock Price (October 2025) $288.46
10-Year Growth 98.46%
20-Year Growth 194.25%
Market Cap (October 2025) $159.52 Billion

20-Year Performance Chart


Interactive visualization of ISRG vs AMGN stock performance (2005-2025)

20-Year Performance Data


Year ISRG AMGN
2025 +1.96% +18.00%
2024 +57.70% -9.71%
2023 +27.00% +13.89%
2022 -26.29% +19.52%
2021 +34.74% +2.34%
2020 +36.98% -1.59%
2019 +26.85% +29.44%
2018 +27.63% +13.21%
2017 +70.59% +18.60%
2016 +15.85% -5.24%
2015 +3.92% +3.56%
2014 +39.19% +40.22%
2013 -22.80% +30.34%
2012 +3.96% +37.05%
2011 +72.12% +16.79%
2010 -16.52% -4.89%
2009 +129.16% -4.10%
2008 -60.80% +23.93%
2007 +241.87% -32.11%
2006 -17.19% -15.00%
2005 +34.36% +4.74%
20-Year Average Return for ISRG 9.71%
20-Year Average Return for AMGN 32.30%

24 Months Performance


Month ISRG AMGN
October 2025 +21.97% -0.02%
September 2025 -4.66% -1.65%
August 2025 -2.03% -2.30%
July 2025 -10.58% +1.58%
June 2025 -1.79% -3.21%
May 2025 +6.80% +2.45%
April 2025 +3.92% -5.21%
March 2025 -12.65% +0.25%
February 2025 -0.93% +7.50%
January 2025 +9.13% +10.08%
December 2024 -3.85% -6.28%
November 2024 +7.04% -10.68%
October 2024 +3.94% -0.05%
September 2024 +1.62% -2.51%
August 2024 +9.25% +0.19%
July 2024 +1.92% +6.90%
June 2024 +10.15% +1.64%
May 2024 +8.18% +11.05%
April 2024 -6.14% -3.22%
March 2024 +0.30% +1.42%
February 2024 +0.46% -14.97%
January 2024 +14.27% +5.67%
December 2023 +7.03% +5.71%
November 2023 +14.93% +4.19%
24 Months Average Return for ISRG 0.36%
24 Months Average Return for AMGN 3.26%

Ready to Make Informed Investment Decisions?

Get access to comprehensive historical stock data and professional analysis to power your investment research and portfolio decisions.